Coronavirus (COVID-19) Advocacy
The ADA is lobbied Congress and the administration to protect dental patients and staff who are providing urgent and emergency care during the COVID-19 pandemic. The ADA is also lobbed to help dental practices stay viable during (and following) prolonged periods of reduced hours or closure. Visit ada.org to learn more about the Coronavirus (COVID-19) advocacy efforts.
Antibiotic could eliminate gum disease-causing pathogen without harming healthy bacteria
Oct 3, 2024
ADA Forsyth scientists have discovered that narrow-spectrum antibiotic FP-100, or hygromycin A, can eradicate Fusobacterium nucleatum.
https://adanews.ada.org/ada-news/2024/october/antibiotic-could-eliminate-gum-disease-causing-pathogen-without-harming-healthy-bacteria/
